ISDA: 3OKI

Deposition Date 2010-08-25

Release Date 2010-12-29

Last Version Date 2024-04-03

Entry Detail

PDB ID:

3OKI

Keywords:

HORMONE RECEPTOR

Title:

Crystal structure of human FXR in complex with (2S)-2-[2-(4-chlorophenyl)-1H-benzimidazol-1-yl]-N,2-dicyclohexylethanamide

Biological Source:

Source Organism(s):

Homo sapiens (Taxon ID: 9606)

Expression System(s):

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.00 Å

R-Value Free:

0.27

R-Value Work:

0.24

R-Value Observed:

0.24

Space Group:

C 2 2 21

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Bile acid receptor
Gene (Uniprot):NR1H4
Mutagens:E281A, E354A
Chain IDs:A, C
Chain Length:233
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:Q96RI1 Pfam ID:PF00104

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:peptide of Nuclear receptor coactivator 1
Gene (Uniprot):NCOA1
Chain IDs:B, D
Chain Length:14
Number of Molecules:2
Biological Source:

UniProt ID:Q15788 EC:2.3.1.48

Ligand Molecules

OKI

Primary Citation

Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetes

Richter, H.G.F, Benson, G.M, Blum, D, Chaput, E, Feng, S, Gardes, C, Grether, U, Hartman, P, Kuhn, B, Martin, R.E, Plancher, J.-M, Rudolph, M.G, Schuler, F, Taylor, S, Bleicher, K.H.Show

Bioorg.Med.Chem.Lett. 21 191 194 (2010)

PMID: 21134747 DOI: 10.1016/j.bmcl.2010.11.039

Abstact

Herein we describe the synthesis and structure activity relationship of a new class of FXR agonists identified from a high-throughput screening campaign. Further optimization of the original hits led to molecules that were highly active in an LDL-receptor KO model for dyslipidemia. The most promising candidate is discussed in more detail.

Legend

Protein

Chemical

Disease

Primary Citation of related structures

Abstact

Feedback Form